Makhoul I, Atiq M, Alwbari A, Kieber-Emmons T. Breast cancer immunotherapy: an update. Breast Cancer: Basic Clin Res. 2018;12:1178223418774802.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA A Cancer J Clin. 2021;71(3):209–49.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021.
Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA: A Cancer J Clin. 2022;72(6):524–41.
Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563–91.
Buist DS, Newton KM, Miglioretti DL, Beverly K, Connelly MT, Andrade S, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004;104:1042–50.
DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA: A Cancer J Clin. 2016;66(1):31–42.
Allahqoli L, Mazidimoradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Front Oncol. 2022;12: 921015.
PubMed PubMed Central Google Scholar
IfHMa E. Protocol for the global burden of diseases, injuries, and risk factors study (GBD) version 4.0. Global burden of diseases, injuries, and risk factors study; 2020.
Aizaz M, Khan M, Khan F, Munir A, Ahmad S, Obeagu E. Burden of breast cancer: developing countries perspective. Int J Innovative Appl Res. 2023;11(1):31–7.
Obeagu EI, Babar Q, Vincent C, Udenze CL, Eze R, Okafor CJ, et al. Therapeutic targets in breast cancer signaling: a review. J Pharm Res Int. 2021;33(56A):82–99.
Ibekwe AM, Obeagu EI, Ibekwe CE, Onyekwuo C, Ibekwe CV, Okoro AD, et al. Challenges of exclusive breastfeeding among working class women in a teaching hospital South East Nigeria. J Pharm Res Inte. 2022;34(46A):1.
Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387.
CAS PubMed PubMed Central Google Scholar
Duggan C, Dvaladze A, Rositch AF, Ginsburg O, Yip CH, Horton S, et al. The breast health global initiative 2018 global summit on improving breast healthcare through resource-stratified phased implementation: methods and overview. Cancer. 2020;126:2339–52.
Dimkpa JN, Sheriff HB. Prevalence of breast cancer amongst patients attending 44 Nigerian army reference hospitaL Kaduna State, NIGERIA. J Health Syst Res 2024.
Collaborators GDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.
Collaborators GD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1160–203.
Fantom N, Serajuddin U. The World Bank’s classification of countries by income: The World Bank; 2016.
Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96(1):5–21.
Evaluation IfHMa. PROtocol for the global burden of diseases, injuries, and risk factors study (GBD) Version 4.0. Global burden of diseases, injuries, and risk factors study; 2020.
Mazidimoradi A, Momenimovahed Z, Khalajinia Z, Allahqoli L, Salehiniya H, Alkatout I. The global incidence, mortality, and burden of uterine cancer in 2019 and correlation with SDI, tobacco, dietary risks, and metabolic risk factors: An Ecol Study. 2024;7(1):e1835.
Zhang J, Lu Y, Zhang N, Yu Z, Li H, He R, et al. Global burden of female breast cancer and its association with socioeconomic development status, 1990–2044. Cancer Rep. 2023;6: e1827.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev. 2015;16(14):6081–7. https://doi.org/10.7314/APJCP.2015.16.14.6081.
Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:1–11.
Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, et al. Risk factor modification and projections of absolute breast cancer risk. J National Cancer Inst. 2011;103(13):1037–48. https://doi.org/10.1093/jnci/djr172.
Kish JK, Yu M, Percy-Laurry A, Altekruse SF. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in surveillance, epidemiology, and end results (SEER) registries. J Natl Cancer Inst Monogr. 2014;2014(49):236–43. https://doi.org/10.1093/jncimonographs/lgu020.
Article PubMed PubMed Central Google Scholar
Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst. 2013;105(8):515–25. https://doi.org/10.1093/jnci/djt023.
Article CAS PubMed Google Scholar
Pathy NB, Yip CH, Taib NA, Hartman M, Saxena N, Iau P, et al. Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast. 2011;20:S75–80.
Hollingsworth AB. Redefining the sensitivity of screening mammography: a review. Am J Surg. 2019;218(2):411–8.
PubMed PubMed Central Google Scholar
Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, et al. Differences in mammographic density between Asian and Caucasian populations: a comparative analysis. Breast Cancer Res Treat. 2017;161:353–62.
Bhoo-Pathy N, Yip C-H, Hartman M, Uiterwaal CS, Devi BC, Peeters PH, et al. Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer. 2013;49(3):703–9.
Lv L, Zhao B, Kang J, Li S, Wu H. Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: results from the global burden of disease study 2019. Front Public Health. 2023;10:1078191. https://doi.org/10.3389/fpubh.2022.
Article PubMed PubMed Central Google Scholar
Arthur RS, Wang T, Xue X, Kamensky V, Rohan TE. Genetic factors, adherence to healthy lifestyle behavior and risk of invasive breast cancer among women in the UK Biobank. JNCI: J National Cancer Inst. 2020;112(9):893–901. https://doi.org/10.1093/jnci/djz241.
Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, et al. Dietary modification and breast cancer mortality: long-term follow-up of the women’s health initiative randomized trial. J Clin Oncol. 2020;38(13):1419–28. https://doi.org/10.1200/JCO.19.00435.
Article PubMed PubMed Central Google Scholar
Espina C, McKenzie F, Dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann Epidemiol. 2017;27(10):659-71.e7. https://doi.org/10.1016/j.annepidem.2017.09.007.
Article PubMed PubMed Central Google Scholar
Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: greater socioeconomic inequity in America. Clin Invest Med. 2009;32(3):E239–49.
PubMed PubMed Central Google Scholar
Sarvi F, Nadali A, Khodadost M, Moghaddam MK, Sadeghifar M. Application of poisson hidden Markov model to predict number of PM2. 5 exceedance days in Tehran during 2016–2017. Avicenna J Environ Health Eng. 2017;4(1):58031.
Namiranian N, Moradi-Lakeh M, Razavi-Ratki SK, Doayie M, Nojomi M. Risk factors of breast cancer in the Eastern Mediterranean Region: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15(21):9535–41.
Khatib O, Aljurf M. Cancer prevention and control in the Eastern Mediterranean region: the need for a public health approach. Hematol Oncol Stem Cell Ther. 2008;1(1):44–52.
Comments (0)